Interim Manager Cost: Day Rate and Fees – Heer Consulting

Fees

What does an interim manager cost?

The day rate at Heer Consulting is EUR 1,000 to 1,500 plus VAT. Where it falls within that range depends on the mandate and the scope of the engagement.

In short: EUR 1,000–1,500 per working day plus VAT. We agree the exact terms in an initial conversation.

What the day rate depends on

Mandate and responsibility: An interim CEO with full P&L responsibility is a different mandate from a focused assignment such as heading up sales.

Scope: Number of working days per week and length of the engagement. Mandates typically run 3 to 12 months.

The individual case: starting position, urgency and the task within the company. That is why I quote a range, not a fixed price.

Worked example

Arithmetic only, not an offer: at 3 working days per week over about 26 weeks (roughly six months) that is 78 working days. At EUR 1,000 to 1,500 per day this comes to EUR 78,000 to 117,000 plus VAT. The actual scope depends on your situation.

Interim manager or permanent hire?

A day rate cannot be compared directly with a salary. A permanent hire also brings benefits, the cost of the search and the time until the role is filled. An interim manager is typically ready to start within a few days, needs no onboarding and is only in the company for the duration of the mandate.

When an interim manager makes sense

Typical situations are a leadership vacancy, an assignment as interim CEO in Medtech, an interim sales director or market entry into DACH. My working area covers Zurich, Lucerne, Basel, Zug, Bern, Munich, Frankfurt and Hamburg.

Frequently asked questions

What does an interim manager cost per day at Heer Consulting?

EUR 1,000 to 1,500 plus VAT, depending on the mandate and its scope.

How long does a typical mandate last?

Usually 3 to 12 months.

How quickly can an engagement start?

Typically within a few days, without onboarding.

Which companies does Heer Consulting work for?

Mid-sized companies with 50 to 500 employees in Medtech, Pharma, Dental and plastics, as well as private equity firms with a healthcare portfolio.

Request an initial conversation

As of October 2026

📅 Book a call